stockrow
Friday 6 November 2026
Export VREX’s income statement to Excel — free account
VAREX IMAGING
VREX Healthcare Medical Devices
VAREX IMAGING’s revenue for fiscal 2025 (year ended September 2025) was $844.6 million, up 4.14% from fiscal 2024.
- Revenue
- +3.69%
- EPS
- +117.2%
- Free cash flow
- +757.1%
- Total debt
- −5.55%
Quarter to June 2026, against a year earlier
18.44
0.00
0.00%
Follow VREX
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 5 | 3 | 6 |
| (13.65%) | (12.96%) | (15.72%) | 4.51% | ||
| (6.06%) | (5.57%) | (6.76%) | 2.03% | ||
ROIC |
(2.49%) | (2.01%) | (2.62%) | 5.95% | |
Return on Tangible Assets |
(11.48%) | (10.73%) | (13.93%) | 3.59% | |
Average Days of Receivables |
67.68 | 62.58 | 63.04 | 61.06 | |
Free Cash Flow per Share |
0.45 | (0.32) | (0.73) | (0.48) | |
Free Cash Flow |
18.80 | (13.30) | (30.80) | (20.20) | |
Capital Expenditures |
(22.90) | (29.40) | (28.80) | (31.50) | |
| Other line items | |||||
Cash ROIC |
1.86% | (1.35%) | (3.33%) | (2.11%) | |
Accounts Receivable Turnover |
5.37 | 6.00 | 5.84 | 6.14 | |
Accounts Payable Turnover |
8.59 | 7.79 | 6.82 | 7.37 | |
Inventory Turnover |
1.96 | 1.85 | 1.80 | 1.76 | |
Average Days of Payables |
46.04 | 51.19 | 61.75 | 53.65 | |
Days of Inventory on Hand |
197.22 | 212.80 | 222.09 | 223.01 | |
Tax Rate |
0.18 | 0.16 | 0.10 | (0.19) | |
Research and Development Expense of Revenue |
10.79% | 10.45% | 10.44% | 10.57% | |
Selling, General and Administrative Expense of Revenue |
15.78% | 15.47% | 15.81% | 15.41% | |
Share Based Compensation of Revenue |
1.78% | 1.72% | 1.74% | 1.73% | |
Interest Coverage |
(0.78) | (0.67) | (0.74) | 1.86 | |
Operating CF/Net income |
(0.59) | (0.24) | 0.02 | 0.51 | |
Depreciation/Fixed assets |
0.78 | 0.77 | 0.75 | 0.17 | |
Capex/Depreciation |
(0.18) | (0.24) | (0.23) | (1.09) | |
Revenue per Share |
20.40 | 20.44 | 20.42 | 20.55 | |
Operating CF per Share |
1.01 | 0.39 | (0.05) | 0.27 | |
Capex per Share |
(0.55) | (0.70) | (0.69) | (0.75) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.04 |
Columns are period end dates · fundamentals updated 25 Oct 2026